BRD4 and nut midline carcinoma: Its activity was first described in NUT midline carcinoma, a rare, aggressive epithelial cancer genetically defined by a chromosomal translocation of BRD4 with NUT (47), where JQ1 inhibition of BRD4 induced squamous cell differentiation and tumor regression in a tumor primagraft model (48).